Andrew Massaband

Andrew Massaband practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Andrew Massaband's NPI, 1609495886, was assigned on April 8, 2020. Andrew Massaband graduated from St. George's University School of Medicine in 2020. Andrew Massaband's California license number on file is A-191298.

Andrew Massaband's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.

Andrew Massaband's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. Andrew Massaband is also affiliated with HCA Florida North Florida Hospital. The medical group on file is Vituity. Dmand AI also links Andrew Massaband to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Andrew Massaband practices, 4 sites in all. Vendor and product names are available with a free account.

Hospitalist is Andrew Massaband's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Andrew Massaband is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Andrew Massaband's licenses on file in 2 states: California and Florida.

CMS data shows 479 Medicare services from Andrew Massaband across 6 procedure codes in 2024, for 268 Medicare patients. Medicare paid $39,596 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 268 Medicare patients who saw Andrew Massaband in 2024. The largest group is 65 to 74, with 91 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 3.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Andrew Massaband's median patient age at 69, with 55% women.

In 2024, Andrew Massaband wrote 222 Medicare Part D claims for 120 patients. 88% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $165 in total drug cost. In 2021, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Andrew Massaband for performance year 2024, reported as part of a group. Andrew Massaband accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 7 general payments to Andrew Massaband from 4 drug and device companies from 2022 to 2023. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $214.

Andrew Massaband graduated from St. George's University School of Medicine in 2020.

Andrew Massaband is in network with 8 carriers, including United Healthcare, Aetna and Elevance. PPO plans come from the most carriers, 4. Check the plan with the practice before a visit.